KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Depreciation and Depletion (2016 - 2020)

Palvella Therapeutics (PVLA) has disclosed Depreciation and Depletion for 7 consecutive years, with $530000.0 as the latest value for Q2 2020.

  • On a quarterly basis, Depreciation and Depletion rose 1161.9% to $530000.0 in Q2 2020 year-over-year; TTM through Jun 2020 was $1.3 million, a 136.59% increase, with the full-year FY2023 number at $1.8 million, down 21.74% from a year prior.
  • Depreciation and Depletion was $530000.0 for Q2 2020 at Palvella Therapeutics, up from $339000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $530000.0 in Q2 2020 to a low of -$11764.0 in Q2 2016.
  • A 5-year average of $157222.2 and a median of $133000.0 in 2017 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: plummeted 115.39% in 2016, then soared 1161.9% in 2020.
  • Palvella Therapeutics' Depreciation and Depletion stood at $185613.0 in 2016, then fell by 28.88% to $132000.0 in 2017, then soared by 47.73% to $195000.0 in 2018, then grew by 19.49% to $233000.0 in 2019, then soared by 127.47% to $530000.0 in 2020.
  • Per Business Quant, the three most recent readings for PVLA's Depreciation and Depletion are $530000.0 (Q2 2020), $339000.0 (Q1 2020), and $233000.0 (Q4 2019).